Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126 · see citing works

A role for glucagon-like peptide-1 in the central regulation of feeding

Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · see citing works

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402 · see citing works

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study

Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297 · see citing works

Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas.

Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000 · see citing works

Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906 · see citing works

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

Drucker, D. J., Erlich, P., Asa, S. L., & Brubaker, P. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7911 · Cited by 880 · see citing works

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851 · see citing works

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene

Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793 · see citing works

Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing

Mojsov, S., Heinrich, G., Wilson, I. B., Ravazzola, M., Orci, L., & Habener, J. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67324-7 · Cited by 724 · see citing works

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem

Larsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663 · see citing works

Glucagon-Like Peptides

Drucker, D. J. (1998) · Diabetes · doi:10.2337/diab.47.2.159 · Cited by 602 · see citing works

Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis

Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589 · see citing works

Enhancing Incretin Action for the Treatment of Type 2 Diabetes

Drucker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2929 · Cited by 576 · see citing works

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.

Yamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J., Lopez, M. E., Hollenberg, A., Baggio, L., Saper, C., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15595 · Cited by 544 · see citing works

Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain.

Usdin, T. B., Mezey, E., Button, D. C., Brownstein, M. J., & Bonner, T. I. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243312 · Cited by 534 · see citing works

International Union of Pharmacology. XXXV. The Glucagon Receptor Family

Mayo, K. E., Miller, L. J., BATAILLE, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 507 · see citing works

Biological actions and therapeutic potential of the glucagon-like peptides

Drucker, D. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.31068 · Cited by 500 · see citing works

Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites

Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · see citing works

Oxyntomodulin Suppresses Appetite and Reduces Food Intake in Humans

Cohen, M. A., Ellis, S. M., le Roux, C. W., Batterham, R. L., Park, A., Patterson, M., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030421 · Cited by 473 · see citing works

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers

Edwards, C. M. B., Stanley, S. A., Davis, R. P., Brynes, A. E., Frost, G. S., Seal, L., Ghatei, M. A., & Bloom, S. R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.1.e155 · Cited by 464 · see citing works

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

Yamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J. M., Lopez, M. E., Hollenberg, A. N., Baggio, L., Saper, C. B., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215595 · Cited by 429 · see citing works

Minireview: The Glucagon-Like Peptides

Drucker, D. J. (2001) · Endocrinology · doi:10.1210/endo.142.2.7983 · Cited by 421 · see citing works

Entry of exendin-4 into brain is rapid but may be limited at high doses

Kastin, A., & Akerstrom, V. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802206 · Cited by 362 · see citing works

Peripheral Oxyntomodulin Reduces Food Intake and Body Weight Gain in Rats

Dakin, C. L., Small, C. J., Batterham, R. L., Neary, N. M., Cohen, M. A., Patterson, M., Ghatei, M. A., & Bloom, S. R. (2004) · Endocrinology · doi:10.1210/en.2003-1338 · Cited by 342 · see citing works

Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical study

Jin, S.-L. C., Han, V. K. M., Simmons, J. G., Towle, A. C., Lauder, J. M., & Lund, P. K. (1988) · The Journal of Comparative Neurology · doi:10.1002/cne.902710405 · Cited by 335 · see citing works

Exendin-4 Decelerates Food Intake, Weight Gain, and Fat Deposition in Zucker Rats

Szayna, M., Doyle, M. E., Betkey, J. A., Holloway, H. W., Spencer, R. G. S., Greig, N. H., & Egan, J. M. (2000) · Endocrinology · doi:10.1210/endo.141.6.7490 · Cited by 303 · see citing works

The Diverse Roles of Specific GLP-1 Receptors in the Control of Food Intake and the Response to Visceral Illness

Kinzig, K. P., D’Alessio, D. A., & Seeley, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10470.2002 · Cited by 295 · see citing works

Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites

Yamamoto, H., Kishi, T., Lee, C. E., Choi, B. J., Fang, H., Hollenberg, A. N., Drucker, D. J., & Elmquist, J. K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02939.2003 · Cited by 294 · see citing works

Oxyntomodulin Inhibits Food Intake in the Rat

Dakin, C. L., Gunn, I., Small, C. J., Edwards, C. M. B., Hay, D. L., Smith, D. M., Ghatei, M. A., & Bloom, S. R. (2001) · Endocrinology · doi:10.1210/endo.142.10.8430 · Cited by 282 · see citing works

The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake

Tang‐Christensen, M., Larsen, P. J., Thulesen, J., Rømer, J., & Vrang, N. (2000) · Nature Medicine · doi:10.1038/77535 · Cited by 269 · see citing works

Glucagon gene expression in vertebrate brain.

Drucker, D. J., & Asa, S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68261-4 · Cited by 265 · see citing works

Systemic Administration of the Long-Acting GLP-1 Derivative NN2211 Induces Lasting and Reversible Weight Loss in Both Normal and Obese Rats

Larsen, P. J., Fledelius, C., Knudsen, L. B., & Tang‐Christensen, M. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2530 · Cited by 258 · see citing works

Colocalization of Glucagon‐Like Peptide‐1 (GLP‐1) Receptors, Glucose Transporter GLUT‐2, and Glucokinase mRNAs in Rat Hypothalamic Cells: Evidence for a Role of GLP‐1 Receptor Agonists as an Inhibitory Signal for Food and Water Intake

Navarro, M. A., de Fonseca, F. R., Álvarez, E., Chowen, J. A., Zueco, J. A., Gomez, R., Eng, J., & Blázquez, E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67051982.x · Cited by 233 · see citing works

To Eat or Not to Eat — How the Gut Talks to the Brain

Körner, J., & Leibel, R. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038114 · Cited by 202 · see citing works

Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus.

Shughrue, P. J., Lane, M. V., & Merchenthaler, I. J. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895391 · Cited by 175 · see citing works

Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice.

Pederson, R. A., Satkunarajah, M., McIntosh, C. H. S., Scrocchi, L. A., Flamez, D., Schuit, F. C., Drucker, D. J., & Wheeler, M. B. (1998) · Diabetes · doi:10.2337/diabetes.47.7.1046 · Cited by 167 · see citing works

Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileum

BATAILLE, D., Coudray, A. M., Carlqvist, M., Rosselin, G., & Mutt, V. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)80708-4 · Cited by 162 · see citing works

Isolation of glucagon‐37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno‐ileum

BATAILLE, D., Tatemoto, K., Gespach, C. P., Jörnvall, H., Rosselin, G., & Mutt, V. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)80709-6 · Cited by 151 · see citing works

Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats

Dakin, C. L., Small, C. J., Park, A. J., Seth, A., Ghatei, M. A., & Bloom, S. R. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00233.2002 · Cited by 142 · see citing works

Importance of Small Bowel Peptides for the Improved Glucose Metabolism 20 Years after Jejunoileal Bypass for Obesity

Näslund, E. B., Bäckman, L., Holst, J. J., Theodorsson, E., & Hellström, P. M. (1998) · Obesity Surgery · doi:10.1381/096089298765554449 · Cited by 136 · see citing works

Agouti and Agouti-related Protein: Analogies and Contrasts

Dinulescu, D. M., & Cone, R. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6695 · Cited by 134 · see citing works

Oxyntomodulin from distal gut

Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01538078 · Cited by 133 · see citing works

Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.

Wheeler, M. B., Gelling, R. W., McIntosh, C. H., Georgiou, J., Brown, J. C., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.10.7664683 · Cited by 130 · see citing works

Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives

Meier, J. J., Gallwitz, B., Schmidt, W. E., & Nauck, M. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01434-6 · Cited by 129 · see citing works

Glucagon-like Peptide (GLP)-2 Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor Signaling

Lovshin, J. A., Estall, J. L., Yusta, B., Brown, T. J., & Drucker, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009382200 · Cited by 125 · see citing works

Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats

Donahey, J. C. K., van Dijk, G., Woods, S. C., & Seeley, R. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01057-3 · Cited by 121 · see citing works

The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans

Flint, A., Raben, A., Jf, R., Holst, J. J., & Astrup, A. V. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801126 · Cited by 120 · see citing works

Oxyntomodulin (glicentin-(33–69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs

Baldissera, F. G. A., Holst, J. J., Knuhtsen, S., Hilsted, L., & Nielsen, O. V. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90099-7 · Cited by 114 · see citing works

The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor

Nishizawa, M., Nakabayashi, H., Kawai, K., Ito, T., Kawakami, S., Nakagawa, A., Niijima, A., & Uchida, K. (2000) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(99)00086-7 · Cited by 110 · see citing works

Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line.

Gros, L., Thorens, B., BATAILLE, D., & Kervran, A. (1993) · Endocrinology · doi:10.1210/endo.133.2.8102095 · Cited by 104 · see citing works

Identification of Glucagon-like Peptide-2 (GLP-2)-activated Signaling Pathways in Baby Hamster Kidney Fibroblasts Expressing the Rat GLP-2 Receptor

Yusta, B., Somwar, R., Wang, F., Munroe, D. G., Grinstein, S., Klip, A., & Drucker, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30459 · Cited by 103 · see citing works

No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects

Sørensen, L. B., Flint, A., Raben, A., Hartmann, B., Holst, J. J., & Astrup, A. V. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802247 · Cited by 101 · see citing works

Glucagon-Like Peptide 21

Drucker, D. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7386 · Cited by 97 · see citing works

Dual Glucagon Recognition by Pancreatic β-Cells via Glucagon and Glucagon-Like Peptide 1 Receptors

Moens, K., Flamez, D., Schravendijk, C. V., Ling, Z., PIPELEERS, D. G., & Schuit, F. C. (1998) · Diabetes · doi:10.2337/diab.47.1.66 · Cited by 97 · see citing works

Cell signalling of the GLP-1 action in rat liver

Redondo, A. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00146-1 · Cited by 96 · see citing works

Plasma Enteroglucagon after Jejunoileal Bypass with 3:1 or 1:3 Jejunoileal Ratio

Holst, J. J., Sørensen, T. I. A., Andersen, A. N., STADIL, F., Andersen, B., Lauritsen, K. B., & Klein, H. C. (1979) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527909179871 · Cited by 95 · see citing works

Synthesis and expression of a gene for the rat glucagon receptor. Replacement of an aspartic acid in the extracellular domain prevents glucagon binding.

Carruthers, C. J., Unson, C. G., Kim, H. N., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62047-8 · Cited by 80 · see citing works

Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.

Flamez, D., Breusegem, A. V., Scrocchi, L. A., Quartier, E., PIPELEERS, D. G., Drucker, D. J., & Schuit, F. C. (1998) · Diabetes · doi:10.2337/diabetes.47.4.646 · Cited by 71 · see citing works

Oxyntomodulin: A cAMP-Dependent Stimulus of Rat Parietal Cell Function via the Receptor for Glucagon-Like Peptide-1 (7-36)NH 2

Schepp, W., Dehne, K., Riedel, T., Schmidtler, J., Schaffer, K., & Classen, M. (2009) · Digestion · doi:10.1159/000201367 · Cited by 56 · see citing works

Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and -4

Thum, A., Hupe-Sodmann, K., Göke, R., Voigt, K., Göke, B., & McGregor, G. P. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-29087 · Cited by 55 · see citing works

Oxyntomodulin and Glicentin: Brain-Gut Peptides in the Rat*

Blache, P., Kervran, A., & BATAILLE, D. (1988) · Endocrinology · doi:10.1210/endo-123-6-2782 · Cited by 49 · see citing works

Glucagon and Related Peptides in Fetal Rat Hypothalamusin Vivoandin Vitro*

Lui, E. Y. T., Asa, S. L., Drucker, D. J., et al. (1990) · Endocrinology · doi:10.1210/endo-126-1-110 · Cited by 44 · see citing works

Oxyntomodulin Inhibits Pancreatic Secretion Through the Nervous System in Rats

Anini, Y., Jarrousse, C., Chariot, J., Nagain, C., Yanaihara, N., Sasaki, K., Bernad, N., Le‐Nguyen, D., BATAILLE, D., & Roz, C. (2000) · Pancreas · doi:10.1097/00006676-200005000-00003 · Cited by 36 · see citing works

Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro

Myojo, S., Tsujikawa, T., Sasaki, M., Fujiyama, Y., & Bamba, T. (1997) · Journal of Gastroenterology · doi:10.1007/bf02934484 · Cited by 31 · see citing works

Inhibition of gastric acid secretion by oxyntomodulin and its 19-37 fragment in the conscious rat

Jarrousse, C., Carles-Bonnet, C., Niel, H., et al. (1993) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1993.264.5.g816 · Cited by 29 · see citing works

Gut and Pancreatic Hormones after Jejunoileal Bypass with 3:1 or 1:3 Jejunoileal Ratio

Sørensen, T. I. A., Lauritsen, K. B., Holst, J. J., et al. (2009) · Digestion · doi:10.1159/000198880 · Cited by 24 · see citing works

Oxyntomodulin stimulates intestinal glucose uptake in rats

Collie, N. L., Zhu, Z., Jordan, S. L., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178688 · Cited by 24 · see citing works

Local, exendin-(9—39)-insensitive, site of action of GLP-1 in canine ileum

Daniel, E. E., Anvari, M., Fox-Threlkeld, J.-A. E. T., & McDonald, T. J. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00110.2002 · Cited by 22 · see citing works

Geometry of rubrospinal, rubroolivary, and local circuit neurons in the macaque red nucleus

Burman, K. J., Darian‐Smith, C., & Darian-Smith, I. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000724)423:2 · Cited by 16 · see citing works

In vitro insulinomimetric effects of GLP‐1 in liver, muscle and fat

Valverde, I., & Villanueva‐Peñacarrillo, M. L. (1996) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1996.43257000.x · Cited by 12 · see citing works

Oxyntomodulin and related peptides control somatostatin secretion in RIN T3 cells

Tani, T., Quellec, A. L., Jarrousse, C., et al. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90107-9 · Cited by 8 · see citing works

Biology of Incretins: GLP-1 and GIP

Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · see citing works

Glucagon-like peptide 1 (GLP-1)

Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868 · see citing works

Gastrointestinal regulation of food intake

Cummings, D. E., & Overduin, J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30227 · Cited by 1,216 · see citing works

The role of incretins in glucose homeostasis and diabetes treatment

Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824 · see citing works

Gut hormones and the regulation of energy homeostasis

Murphy, K. G., & Bloom, S. R. (2006) · Nature · doi:10.1038/nature05484 · Cited by 778 · see citing works

Update on the treatment of type 2 diabetes mellitus

Marín-Peñalver, J. J., Martín-Timón, I., Sevillano-Collantes, C., & Cañizo-Gómez, F. J. D. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.354 · Cited by 647 · see citing works

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

Day, J. W., Ottaway, N., Patterson, J. T., Gelfanov, V., Smiley, D., Gidda, J., Findeisen, H., Bruemmer, D., Drucker, D. J., Chaudhary, N., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.209 · Cited by 641 · see citing works

The gut and energy balance: visceral allies in the obesity wars

Badman, M. K., & Flier, J. S. (2005) · Science · doi:10.1126/science.1109951 · Cited by 532 · see citing works

The New Biology and Pharmacology of Glucagon

Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419 · see citing works

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

Pocai, A., Carrington, P. E., Adams, J. R., Wright, M., Eiermann, G., Zhu, L., Du, X., Petrov, A., Lassman, M. E., Jiang, G., et al. (2009) · Diabetes · doi:10.2337/db09-0278 · Cited by 409 · see citing works

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

Silva, A. D., & Bloom, S. R. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.1.10 · Cited by 373 · see citing works

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

Wynne, K., Park, A. J., Small, C. J., Meeran, K., Ghatei, M. A., Frost, G. S., & Bloom, S. R. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803344 · Cited by 363 · see citing works

Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS

van Bloemendaal, L., ten Kulve, J. S., la Fleur, S. E., Ijzerman, R. G., & Diamant, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0414 · Cited by 312 · see citing works

GLP-1 Receptor Expression Within the Human Heart

Baggio, L. L., Yusta, B., Mulvihill, E. E., Cao, X., Streutker, C. J., Butany, J., Cappola, T. P., Margulies, K. B., & Drucker, D. J. (2018) · Endocrinology · doi:10.1210/en.2018-00004 · Cited by 312 · see citing works

Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation

Wong, C. K., McLean, B. A., Baggio, L. L., Koehler, J. A., Hammoud, R., Rittig, N., Yabut, J. M., Seeley, R. J., Brown, T. J., & Drucker, D. J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.11.009 · Cited by 304 · see citing works

Role of the gut-brain axis in energy and glucose metabolism

Wachsmuth, H. R., Weninger, S. N., & Duca, F. A. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00677-w · Cited by 269 · see citing works

GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach

Wang, J.-Y., Wang, Q.-W., Yang, X.-Y., Yang, W., Li, D.-R., Jin, J.-Y., Zhang, H.-C., & Zhang, X.-F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1085799 · Cited by 248 · see citing works

The L-cell in nutritional sensing and the regulation of appetite

Spreckley, E. (2015) · Frontiers in Nutrition · doi:10.3389/fnut.2015.00023 · Cited by 198 · see citing works

Anti-obesity therapy: from rainbow pills to polyagonists

Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199 · see citing works

Action and therapeutic potential of oxyntomodulin

Pocai, A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.12.001 · Cited by 191 · see citing works

Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes

Muscogiuri, G., DeFronzo, R. A., Gastaldelli, A., & Holst, J. J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.10.001 · Cited by 171 · see citing works

Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons

Adams, J. M., Pei, H., Sandoval, D. A., Seeley, R. J., Chang, R. B., Liberles, S. D., & Olson, D. P. (2018) · Diabetes · doi:10.2337/db17-1385 · Cited by 159 · see citing works

Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota

Mishra, A. K., Dubey, V., & Ghosh, A. R. (2016) · Metabolism · doi:10.1016/j.metabol.2015.10.008 · Cited by 161 · see citing works

Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake

Cegla, J., Troke, R. C., Jones, B., Tharakan, G., Kenkre, J., McCullough, K. A., Lim, C. T., Parvizi, N., Hussein, M., Chambers, E. S., et al. (2014) · Diabetes · doi:10.2337/db14-0242 · Cited by 159 · see citing works

Molecular mechanisms underlying nutrient-stimulated incretin secretion

Parker, H. E., Reimann, F., & Gribble, F. M. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940900132x · Cited by 155 · see citing works

The intestine as an endocrine organ and the role of gut hormones in metabolic regulation

Bany Bakar, R., Reimann, F., & Gribble, F. M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00830-y · Cited by 144 · see citing works

Activation of murine pre-proglucagon–producing neurons reduces food intake and body weight

Gaykema, R. P., Newmyer, B. A., Ottolini, M., Raje, V., Warthen, D. M., Lambeth, P. S., Niccum, M., Yao, T., Huang, Y., Schulman, I. G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci81335 · Cited by 123 · see citing works

A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

Valdecantos, M. P., Pardo, V., Ruiz, L., Castro‐Sánchez, L., Lanzón, B., Fernández‐Millán, E., García‐Monzón, C., Arroba, A. I., González‐Rodríguez, Á., Escrivá, F., et al. (2017) · Hepatology · doi:10.1002/hep.28962 · Cited by 100 · see citing works

Gut hormone co-agonists for the treatment of obesity: from bench to bedside

Nogueiras, R., Nauck, M. A., & Tschöp, M. H. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00812-z · Cited by 102 · see citing works

Loss of dorsomedial hypothalamic GLP-1 signaling reduces BAT thermogenesis and increases adiposity

Lee, S. J., Sanchez-Watts, G., Krieger, J.-P., Pignalosa, A., Norell, P. N., Cortella, A., Pettersen, K. G., Vrdoljak, D., Hayes, M. R., Kanoski, S. E., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.008 · Cited by 95 · see citing works

Oxyntomodulin: actions and role in diabetes

Holst, J. J., Albrechtsen, N. J. W., Gabe, M. B. N., & Rosenkilde, M. M. (2018) · Peptides · doi:10.1016/j.peptides.2017.09.018 · Cited by 86 · see citing works

Striking the balance: GLP-1/glucagon co-agonism as a treatment strategy for obesity

Hope, D. C. D., Vincent, M. L., & Tan, T. M. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.735019 · Cited by 81 · see citing works

Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4

Baraboi, E.-D., St-Pierre, D. H., Shooner, J., Timofeeva, E., & Richard, D. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00424.2010 · Cited by 79 · see citing works

Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose

Burmeister, M. A., Ayala, J., Drucker, D. J., & Ayala, J. E. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00446.2012 · Cited by 64 · see citing works

Gene therapy for diabetes: Metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model

Samson, S. L., Gonzalez, E. V., Yechoor, V., Bajaj, M., Oka, K., & Chan, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.198 · Cited by 54 · see citing works

Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators

Decara, J., Arrabal, S., Beiroa, D., Rivera, P., Vargas, A., Serrano, A., Pavón, F. J., Ballesteros, J., Dieguez, C., Nogueiras, R., et al. (2016) · BioFactors · doi:10.1002/biof.1295 · Cited by 42 · see citing works

Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates

Elvert, R., Herling, A. W., Bossart, M., Weiss, T., Zhang, B., Wenski, P., Wandschneider, J., Kleutsch, S., Butty, U., Kannt, A., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13212 · Cited by 42 · see citing works

Bowels control brain: gut hormones and obesity

Bewick, G. A. (2012) · Biochemia Medica · doi:10.11613/bm.2012.032 · Cited by 36 · see citing works

Cracking the combination: Gut hormones for the treatment of obesity and diabetes

Alexiadou, K., Anyiam, O., & Tan, T. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12664 · Cited by 34 · see citing works

Unlocking the multifaceted roles of GLP-1: Physiological functions and therapeutic potential

AL-Noshokaty, T. M., Abdelhamid, R., Abdelmaksoud, N. M., Khaled, A., Hossam, M., Ahmed, R., Saber, T., Khaled, S., Elshaer, S. S., & Abulsoud, A. I. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101895 · Cited by 30 · see citing works

Perspectives in weight control in diabetes - survodutide

Klein, T., Augustin, R., & Hennige, A. M. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110779 · Cited by 25 · see citing works

Influence of acute and chronic energy balance changes on circulating concentrations of human peptide YY

Otto, B., Lippl, F., Pfluger, P. T., et al. (2005) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2005-921815

Peptide YY release in anorectic patients after liquid meal

Otto, B., Cuntz, U., Otto, C., Heldwein, W., Riepl, R. L., & Tschöp, M. H. (2006) · Appetite · doi:10.1016/j.appet.2006.06.008 · Cited by 28 · see citing works

Effect of Human Body Weight Changes on Circulating Levels of Peptide YY and Peptide YY3–36

Pfluger, P. T., Kampe, J., Castañeda, T. R., Vahl, T. P., D’Alessio, D. A., Kruthaupt, T., Benoit, S. C., Cuntz, U., Rochlitz, H., Moehlig, M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1425 · Cited by 190 · see citing works

Peptide YY

Katsuura, G., & Inui, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801028-0.00167-7 · Cited by 1 · see citing works

Gastrointestinal Satiety Signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide

Stanley, S. A., Wynne, K., & Bloom, S. R. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00536.2003 · Cited by 131 · see citing works